Bone densitometry and bone biopsy

Best Practice and Research: Clinical Rheumatology

Volumn 19, Issue 3 SPEC. ISS., 2005, Pages 487-501

  Ralston, Stuart H ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Biopsy; BMD; Bone density; Bone disease; Osteoporosis

Indexed keywords

ALENDRONIC ACID; CALCITONIN; CALCIUM; CORTICOSTEROID; DEMECLOCYCLINE; GONADORELIN AGONIST; PREDNISOLONE; RALOXIFENE; RISEDRONIC ACID; TETRACYCLINE; VITAMIN D;

ARTICLE; BONE BIOPSY; BONE DENSITOMETRY; BONE DENSITY; BONE MINERAL; CLINICAL TRIAL; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; DRUG ERUPTION; DRUG LABELING; DRUG RESPONSE; DUAL ENERGY X RAY ABSORPTIOMETRY; FRAGILITY FRACTURE; HEALTH CARE COST; HIP FRACTURE; HUMAN; INTERMETHOD COMPARISON; MEDICAL DECISION MAKING; METABOLIC BONE DISEASE; NAUSEA; NEUTRON ACTIVATION ANALYSIS; OSTEOPOROSIS; PHOTOSENSITIVITY; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RADIATION DOSE; TREATMENT INDICATION; VITAMIN SUPPLEMENTATION;

EID: 20444428353     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2004.11.008     Document Type: Review

References (27)

1. J.A. Kanis L.J Melton III C. Christiansen et al. The diagnosis of osteoporosis J Bone Miner Res 9 1994 1137-1141
2. S.R. Cummings D.M. Black M.C. Nevitt et al. Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group Lancet 341 1993 72-75 [see comments]
3. S.L. Hui C.W. Slemenda & C.C. Johnston Baseline measurement of bone mass predicts fracture in white women Ann Intern Med 111 1989 355-361
4. E.S. Siris P.D. Miller E. Barrett-Connor et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: Results from the National Osteoporosis Risk Assessment JAMA 286 2001 2815-2822
5. C.E. De Laet B.A. van Hout H. Burger et al. Bone density and risk of hip fracture in men and women: Cross sectional analysis Br Med J 315 1997 221-225 [Published erratum appears in BMJ 997;35:916]
6. C.C. Gluer U.J. Reiser C.A. Davis et al. Vertebral mineral determination by quantitative computed tomography (QCT): Accuracy of single and dual energy measurements J Comput Assist Tomogr 12 1988 242-258
7. C.C. Gluer & H.K. Genant Impact of marrow fat on accuracy of quantitative CT J Comput Assist Tomogr 13 1989 1023-1035
8. S. Grampp P. Lang M. Jergas et al. Assessment of the skeletal status by peripheral quantitative computed tomography of the forearm: Short-term precision in vivo and comparison to dual X-ray absorptiometry J Bone Miner Res 10 1995 1566-1576
9. D.W. Dempster F. Cosman E.S. Kurland et al. Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: A paired biopsy study J Bone Miner Res 16 2001 1846-1853
10. A.C. Looker H.W. Wahner W.L. Dunn et al. Updated data on proximal femur bone mineral levels of US adults Osteoporos Int 8 1998 468-489
11. J. Hanson Standardization of proximal femur BMD measurements. International Committee for Standards in Bone Measurement Osteoporos Int 7 1997 500-501
12. K.G. Faulkner & E. Orwoll Implications in the use of T-scores for the diagnosis of osteoporosis in men J Clin Densitom 5 2002 87-93
13. D.M. Black S.R. Cummings D.B. Karpf et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group Lancet 348 1996 1535-1541
14. S.R. Cummings D.M. Black D.E. Thompson et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: Results from the Fracture Intervention Trial JAMA 280 1998 2077-2082
15. B. Ettinger D.M. Black B.H. Mitlak et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene JAMA 282 1999 637-645
16. S.T. Harris N.B. Watts H. Genant et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: A randomized controlled trial. Vertebral efficacy with risedronate therapy (VERT) Study Group JAMA 282 1999 1344-1352 [see comments]
17. M.R. McClung P. Guesens P.D. Miller et al. Effect of risedronate on the risk of hip fracture in elderly women N Engl J Med 344 2001 333-340
18. R. Lindsay D.M. Hart C. Forrest & C. Baird Prevention of spinal osteoporosis in oophorectomised women Lancet ii 1980 1151-1154
19. G.L. Anderson M. Limacher A.R. Assaf et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women's Health Initiative randomized controlled trial JAMA 291 2004 1701-1712
20. S. Wassertheil-Smoller S.L. Hendrix M. Limacher et al. Effect of estrogen plus progestin on stroke in postmenopausal women: The Women's Health Initiative: A randomized trial JAMA 289 2003 2673-2684
21. M.C. Chapuy M.E. Arlot P.D. Delmas & P.J. Meunier Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women Br Med J 308 1994 1081-1082
22. M.C. Chapuy M.E. Arlot F. Duboeuf et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women N Engl J Med 327 1992 1637-1642
23. G.M. Blake & I. Fogelman Interpretation of bone densitometry studies Semin Nucl Med 27 1997 248-260
24. T.P. Van Staa R.F. Laan I.P. Barton et al. Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy Arthritis Rheum 48 2003 3224-3229
25. J.D. Adachi W.G. Bensen J. Brown et al. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis N Engl J Med 337 1997 382-387
26. C.M. Langton & C.F. Njeh (eds.) The Physical Measurement of Bone 2004 Institute of Physics London
27. I. Fogelman & G.M. Blake Different approaches to bone densitometry J Nucl Med 41 2000 2015-2025